Frequency of selected single nucleotide polymorphisms influencing the warfarin pharmacogenetics in Slovak population.

Krajcíová, L'ubica; Petrovic, Robert; Déziová, L'udmila; Chandoga, Ján; Turcáni, Peter

Krajcíová, L'ubica; Petrovic, Robert; Déziová, L'udmila; Chandoga, Ján; Turcáni, Peter.

Affiliation

Krajcíová L; 1st Department of Neurology, University Hospital, Bratislava, Slovakia; Institute of Medical Biology, Genetics and Clinical Genetics, Comenius University Faculty of Medicine and University Hospital, Bratislava, Slovakia.

Eur J Haematol ; 93(4): 320-8, 2014 Oct.

Article in En | MEDLINE | ID: mdl-24750390

Subject(s)

Anticoagulants/pharmacology; Pharmacogenetics; Polymorphism, Single Nucleotide; Warfarin/pharmacology; White People/genetics; Adult; Alleles; Cytochrome P-450 CYP2C9/genetics; Cytochrome P-450 Enzyme System/genetics; Female; Gene Frequency; Genetics, Population; Genotype; Humans; Male; Slovakia; Vitamin K Epoxide Reductases/genetics

Key words

CYP2C9; CYP4F2; GGCX; Slovak population; VKORC1; pharmacogenetic; polymorphism; warfarin

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Pharmacogenetics / Warfarin / Polymorphism, Single Nucleotide / White People / Anticoagulants Type of study: Risk_factors_studies Limits: Adult / Female / Humans / Male Country/Region as subject: Europa Language: En Year: 2014 Type: Article

Fulltext

XML

PubMed Links

Search on Google